Manufacturer:
Merck
Route of Administration:
Subcutaneous
Site of Care:
Outpatient
Website:
phone:
888-637-2502
Approved Indication:
treatment of adults with pulmonary arterial hypertension (PAH, WHO group 1) to increase exercise capacity, improve WHO functional class, and reduce the risk of clinical worsening events
Conditions:
- Pulmonary Arterial Hypertension